Cerus (CERS) Announces Agreement with American Red Cross for Use of INTERCEPT Platelets and Plasma
Tweet Send to a Friend
Cerus Corporation (NASDAQ: CERS) announced today that the American Red Cross has signed a multi-year purchase agreement for the INTERCEPT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
